The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19

Keyphrases

• COVID-19 100%
• Venous Thromboembolism 100%
• Patients with Cancer 100%
• Hospitalized Patients 100%
• Risk Estimation 100%
• Coronavirus Disease (COVID) 100%
• Arterial Thromboembolism 57%
• Low Risk 28%
• ICU Admission 28%
• High Risk 14%
• Clinical High Risk 14%
• Risk Factors 14%
• Cancer Diagnosis 14%
• Confidence Interval 14%
• Bootstrap 14%
• Anticoagulants 14%
• Logistic Regression Model 14%
• Hospitalization 14%
• Cancer Treatment 14%
• D-dimer 14%
• Anticancer Therapy 14%
• C-statistic 14%
• Thrombotic Risk 14%
• Thrombosis Risk 14%
• 3-point 14%
• Multivariable Logistic Regression 14%
• Hispanic Ethnicity 14%
• Vulnerable Populations 14%
• Ultra-high Risk 14%
• Clinical Risk Factors 14%
• Time-varying Data 14%
• Cancer Subtypes 14%
• Ill Patients 14%
• Data-driven Decision Making 14%
• Non-Hispanic 14%
• Active Cancer 14%
• Systemic Anti-cancer Therapy 14%
• Khorana Score 14%

Medicine and Dentistry

• Venous Thromboembolism 100%
• COVID-19 100%
• Arterial Thromboembolism 57%
• Malignant Neoplasm 42%
• Cancer Treatment 28%
• Thrombosis 14%
• Logistic Regression Analysis 14%
• Cancer Diagnosis 14%
• Cancer Therapy 14%
• Antithrombotic 14%
• Cohort Analysis 14%
• D-Dimer 14%
• Vulnerable Population 14%
• Bootstrapping 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Venous Thromboembolism 100%
• Arterial Thromboembolism 40%
• Anticoagulant Agent 10%
• Thrombosis 10%
• D Dimer 10%
• Cohort Study 10%